The Enhanced Electrochemiluminescence technology represent the latest advancements to our immunodiagnostics strategy.
Our eECL (enhanced Electrochemiluminescence) technology offers stronger signals with lower noise levels and higher sensitivity compared to traditional methods. The incubation time is remarkably short at just 5 minutes, with the first report available within 8 minutes, which is very crucial for emergency diagnostics. Currently, we're focusing on offering tests for inflammatory markers and myocardial markers, such as troponin and myosin.
Enhances luminescent markers, magnetic bead coupling, and the regulation of electrochemical process.
Offers a stronger luminous signal, lower noise, and higher sensitivity.
Avoids interference in testing from biotin and streptavidin antibodies in samples.
